{{Rsnum
|rsid=962458
|Chromosome=X
|position=67526122
|Orientation=minus
|GMAF=0.1765
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 2.7 | 6.2 | 91.2
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 63.3 | 19.7 | 17.0
| ASW | 43.9 | 31.6 | 24.6
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 6.9 | 5.0 | 88.1
| LWK | 41.8 | 29.1 | 29.1
| MEX | 3.4 | 8.6 | 87.9
| MKK | 38.5 | 21.8 | 39.7
| TSI | 3.9 | 2.9 | 93.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=23441776
|Title=Androgen receptor genetic variants in male patients with ankylosing spondylitis in Taiwan
}}

{{PMID Auto
|PMID=15570555
|Title=Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study.
|OA=1
}}

{{PMID Auto
|PMID=15902657
|Title=Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia.
|OA=1
}}

{{PMID Auto
|PMID=15994977
|Title=Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=16987421
|Title=A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
|OA=1
}}

{{PMID Auto
|PMID=19190146
|Title=Genetic variation in the androgen receptor gene and endometrial cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=19555469
|Title=A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}